Folic acid + docosahexaenoic acid

Folic acid + docosahexaenoic acid has been studied in 3 papers since 2020: 2 trials in people, 1 review; 1 in the past year. The newest paper, Feb 28, 2026: “Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis”.

Intervention

3 papers study it9 more mention it3 findingsUpdated

PubChemPubChemChEBIChEBI

See all 12 papers on folic acid + docosahexaenoic acid

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Daily oral FA, DHA and their combined use for 6 months significantly improved the full-scale intelligence quotient (FSIQ)”
Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trialEuropean journal of nutrition2020doi:10.1007/s00394-020-02373-3

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Major Research Plan
  • Human trial2

Studies in people

2 studies gave folic acid + docosahexaenoic acid to people and measured what changed.

What changedDesignPeopleSource

down: Decreases amyloid-beta 42

Randomized trial6 months160 peopleover the age of 60MCI patientsJournal of Alzheimer's disease reports, Sep 27, 2024

up: Improves full-scale intelligence quotient

down: Decreases plasma inflammatory cytokines

Randomized trial6 months240 peopleelderlyOlder adults; mild cognitive impairment, compared with placeboEuropean journal of nutrition, Aug 28, 2020

What did studies of folic acid + docosahexaenoic acid find?

3

Studies of folic acid + docosahexaenoic acid measured 3 outcomes: amyloid-beta 42, plasma inflammatory cytokines and full-scale intelligence quotient.

Amyloid-beta 42

downin humans1

1 study
  1. Folic acid + docosahexaenoic acid decreases amyloid-beta 42 in humans.

    “The GEE analysis revealed that over the 6-month intervention, FA supplementation alone, and in combination with DHA led to a significant reduction in Aβ42, Aβ40, and AβPP levels (p < 0.05”

    Human trial6 months

    Cognitive Function After Stopping Folic Acid and DHA Intervention: An Extended Follow-Up Results from the Randomized, Double Blind, Placebo-Controlled Trial in Older Adults with Mild Cognitive Impairment

    Journal of Alzheimer's disease reports

More on Amyloid-beta 42

Plasma inflammatory cytokines

downin humans1

1 study
  1. Folic acid + docosahexaenoic acid decreases plasma inflammatory cytokines in humans (mild cognitive impairment, compared with placebo).

    “Daily oral FA, DHA and their combined use for 6 months significantly decreased plasma inflammatory cytokines compared to the placebo.”

    Human trialmild cognitive impairment, compared with placeboFA 800 μg/d + DHA 800 mg/d6 monthsn = 240

    Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial

    European journal of nutrition

More on Plasma inflammatory cytokines

Full-scale intelligence quotient

upin humans1

1 study
  1. Folic acid + docosahexaenoic acid improves full-scale intelligence quotient in humans (mild cognitive impairment, compared with placebo).

    “Daily oral FA, DHA and their combined use for 6 months significantly improved the full-scale intelligence quotient (FSIQ)”

    Human trialmild cognitive impairment, compared with placeboFA 800 μg/d + DHA 800 mg/d6 monthsn = 240

    Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial

    European journal of nutrition

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 2Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 03 papers in 12 months

See all 12 papers on folic acid + docosahexaenoic acid